Pathstone Holdings
TDOC icon

Pathstone Holdings’s Teladoc Health TDOC Stock Holding History

Pathstone Holdings’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,334
Closed -$186K – 2377
2024
Q1 		$186K Buy
12,334
+662
+6% +$12K ﹤0.01% 2156
2023
Q4 		$253K Buy
+11,672
New +$215K ﹤0.01% 1930

Other funds holding TDOC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Pathstone Holdings's TDOC Position: Q2 2024 in Review

Pathstone Holdings sold out of Teladoc Health (TDOC) in Q2 2024, closing a stake of 12,334 shares — an estimated $186K sold.

Pathstone Holdings first reported a position in TDOC in Q4 2023 and held it in 2 quarters. The position peaked at $253K in Q4 2023. 405 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

  • Pathstone Holdings reported no remaining Teladoc Health position as of Q2 2024 after selling out during the quarter.
  • Pathstone Holdings sold 12,334 Teladoc Health shares in Q2 2024, an estimated $186K.
  • Pathstone Holdings first reported a position in Teladoc Health in Q4 2023 and held it in 2 quarters.
  • Pathstone Holdings's Teladoc Health position peaked at $253K in Q4 2023.
  • 405 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on Pathstone Holdings's 13F filing for Q2 2024, filed 14 Aug 2024.